TRUEMED GROUP LLC- orciprenaline sulfate tablet

Nazione: Stati Uniti

Lingua: inglese

Fonte: NLM (National Library of Medicine)

Principio attivo:

METAPROTERENOL SULFATE (UNII: GJ20H50YF0) (METAPROTERENOL - UNII:53QOG569E0)

Commercializzato da:

Truemed Group LLC

Via di somministrazione:

ORAL

Tipo di ricetta:

PRESCRIPTION DRUG

Stato dell'autorizzazione:

Export only

Scheda tecnica

TRUEMED GROUP LLC- ORCIPRENALINE SULFATE TABLET
TRUEMED GROUP LLC
----------
ORCIPRENALINE SULFATE
TRUEMED GROUP LLC
orciprenaline sulfate tablet
PRODUCT INFORMATION
PRODUCT TYPE
HUMAN PRESCRIPTION DRUG
ITEM CODE (SOURCE)
NDC:82922-035
ROUTE OF ADMINISTRATION
ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH STRENGTH
METAPROTERENOL SULFATE (UNII: GJ20H50YF0) (METAPROTERENOL -
UNII:53QOG569E0)
METAPROTERENOL
SULFATE
20 mg
PRODUCT CHARACTERISTICS
COLOR
white
SCORE
2 pieces
SHAPE
OVAL
SIZE
45mm
FLAVOR
IMPRINT CODE
CONTAINS
PACKAGING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
1
NDC:82922-035-
01
30 in 1 BOTTLE; Type 0: Not a Combination
Product
09/17/2022
Truemed Group LLC
MARKETING INFORMATION
MARKETING
CATEGORY
APPLICATION NUMBER OR MONOGRAPH
CITATION
MARKETING START
DATE
MARKETING END
DATE
Export only
09/17/2022
LABELER -
Truemed Group LLC (004154534)
ESTABLISHMENT
NAME
ADDRESS
ID/FEI
BUSINESS OPERATIONS
Truemed Group LLC
004154534
manufacture(82922-035)
Revised: 8/2022